Latest oppositions filed by Murgitroyd & Company

This table presents recent patent oppositions filed by Murgitroyd & Company against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP3795696Identification And Use Of Circulating Nucleic Acid Tumor MarkersTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITYJan 26, 2024
EP3801437Connector For Connecting A Medical Injection Device To A ContainerBECTON DICKINSON FRANCEOct 4, 2023
EP3119423Treatment Of Cancer Using Chimeric Antigen ReceptorNOVARTIS AGSep 13, 2023
EP3445407Compositions And Methods Of Cellular ImmunotherapyCAFA THERAPEUTICS LIMITEDSep 13, 2023
EP3165600Cell Culture Medium Comprising Small PeptidesLIFE TECHNOLOGIES CORPORATIONAug 2, 2023
EP3377049Crystalline Forms Of Tapentadol Salts And Process For Preparation ThereofKISHORE KUMAR, MUPPAOct 6, 2021
EP3292053A Polypropylene Cap Or Film CompositionFINE ORGANIC INDUSTRIES LIMITEDAug 18, 2021
EP3421613Identification And Use Of Circulating Nucleic Acid Tumor MarkersTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITYMay 19, 2021
EP3475681Method Of And Apparatus For Preparing Samples For Imaging Or Diffraction Experiments Under Cryogenic ConditionsUNIVERSITEIT MAASTRICHTMar 17, 2021
EP3482036Method And Arrangement For Removing A Liner Below SurfaceCALLIDUS CAPITAL B.V.Feb 12, 2021